3 ways to rebuild trust in how we regulate technology
Trust in governance is at an all-time low - and this is a problem. Here are three recommendations for policymakers to help build a more trustworthy - and trusted - governance framework fo...
Elizabeth O’Day, CEO & Founder Olaris Therapeutics
Trust in governance is at an all-time low - and this is a problem. Here are three recommendations for policymakers to help build a more trustworthy - and trusted - governance framework fo...
Your data is key to all developments in biotech. But first we need to find a way of using it that is both progressive and ethical.
Personalized medicine hinges on bringing the right drug to the right patient at the right time.